Market Overview
The oral sleep apnea devices market consists of custom-fitted medical appliances worn during sleep to prevent airway collapse in patients with obstructive sleep apnea. The primary device categories include mandibular advancement devices, which gently shift the lower jaw forward, and tongue retaining devices that hold the tongue in a forward position. As of 2025, the global market stands at roughly $0.64 billion, with projections showing steady expansion through the early 2030s.
- •Market size in 2025: approximately $0.64 billion globally
- •Projected growth rate: 10.29% CAGR through the forecast period
- •Expected market value by 2032: approximately $1.2 billion
- •Primary device types: mandibular advancement devices (MADs) and tongue retaining devices (TRDs)
Growth Drivers
The increasing global prevalence of obstructive sleep apnea, affecting hundreds of millions of adults worldwide, is a primary catalyst for market expansion. Rising obesity rates, sedentary lifestyles, and an aging population contribute to higher OSA diagnosis rates. Additionally, growing patient preference for non-invasive, portable treatment options over continuous positive airway pressure (CPAP) machines fuels demand for oral appliances. Healthcare provider recognition of oral devices as an effective first-line therapy for mild to moderate OSA further supports market growth.
- •Rising global prevalence of obstructive sleep apnea across adult populations
- •Increasing obesity rates contributing to higher OSA diagnosis rates worldwide
- •Patient preference for non-invasive, portable alternatives to CPAP therapy
- •Growing clinical acceptance of oral appliances as first-line treatment for mild to moderate OSA
Segmentation and Regional Analysis
The market is segmented primarily by device type, including mandibular advancement devices and tongue retaining devices, as well as by distribution channel and end-user setting. North America currently holds the largest market share due to high OSA awareness, established healthcare infrastructure, and favorable reimbursement policies. Europe represents the second-largest region, while the Asia-Pacific market is expected to grow rapidly due to increasing diagnosis rates and improving healthcare access.
- •Primary segmentation: mandibular advancement devices (MADs) and tongue retaining devices (TRDs)
- •North America leads market share with high OSA awareness and favorable reimbursement
- •Europe holds significant market position with growing adoption rates
- •Asia-Pacific emerging as fastest-growing region due to rising diagnosis and improving healthcare infrastructure
Trends and Outlook
What are the recent trends and outlook?
The market is moving toward digitally enabled oral appliances with integrated sensors and telemedicine capabilities for remote monitoring and therapy adjustment. Increasing collaboration between dental professionals and sleep medicine specialists is expanding the treatment ecosystem and improving patient outcomes. Regulatory approvals for over-the-counter oral appliances in certain markets are broadening access. The long-term outlook remains strongly positive as technological innovation, rising healthcare spending on sleep disorders, and expanding insurance coverage for oral appliance therapy support continued market expansion beyond 2032.
- •Growing adoption of smart oral appliances with sensors for therapy monitoring and compliance tracking
- •Increased integration of dental and sleep medicine practices for comprehensive OSA treatment
- •Regulatory trends toward expanded access to over-the-counter and at-home oral appliance options
- •Continued market expansion expected as insurance coverage for oral appliance therapy increases globally
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.